Concentrix (NASDAQ:CNXC) Releases Q3 2026 Earnings Guidance

Concentrix (NASDAQ:CNXC) issued an update on its third quarter 2026 earnings guidance on Monday morning. The company provided earnings per share guidance of 2.650-2.770 for the period, compared to the consensus earnings per share estimate of 3.040. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. Concentrix also updated its FY 2026 guidance to 10.830-11.180 EPS.

Concentrix Stock Up 0.9%

NASDAQ:CNXC traded up $0.23 on Monday, hitting $25.23. The stock had a trading volume of 3,077,140 shares, compared to its average volume of 1,607,306. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.18 and a current ratio of 1.18. The stock has a market cap of $1.54 billion, a P/E ratio of -1.17, a price-to-earnings-growth ratio of 0.31 and a beta of 0.43. The firm’s fifty day simple moving average is $25.93 and its two-hundred day simple moving average is $32.17. Concentrix has a 1 year low of $22.05 and a 1 year high of $62.14.

Wall Street Analyst Weigh In

CNXC has been the subject of a number of recent analyst reports. Canaccord Genuity Group reduced their price objective on Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, March 25th. Wall Street Zen cut Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, March 28th. Robert W. Baird lowered their target price on Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 25th. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Finally, Barrington Research reissued an “outperform” rating and set a $38.00 target price on shares of Concentrix in a research report on Monday, June 22nd. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Concentrix has an average rating of “Moderate Buy” and a consensus target price of $44.33.

Insiders Place Their Bets

In other news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the company’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the transaction, the insider owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This represents a 68.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Andre S. Valentine purchased 2,500 shares of the business’s stock in a transaction dated Thursday, April 9th. The shares were purchased at an average price of $27.95 per share, with a total value of $69,875.00. Following the purchase, the chief financial officer directly owned 89,066 shares in the company, valued at $2,489,394.70. This trade represents a 2.89% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Concentrix

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Larson Financial Group LLC increased its stake in shares of Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after purchasing an additional 479 shares in the last quarter. Geneos Wealth Management Inc. raised its position in shares of Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares during the period. Global Retirement Partners LLC lifted its stake in shares of Concentrix by 1,032.5% during the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock valued at $36,000 after buying an additional 795 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Concentrix during the 3rd quarter valued at approximately $69,000. Finally, Kestra Advisory Services LLC bought a new position in Concentrix in the 4th quarter worth approximately $100,000. Institutional investors own 90.34% of the company’s stock.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.